The 2025 China migraine patient guide explains recognizing migraine (pulsating, one-sided, with nausea/light sensitivity), trigger management, acute abortive treatment, and preventive therapy including new CGRP-targeted options.
“Migraine: 2025 China Patient Guide” is part of iMedCompanion’s plain-language library for international patients travelling to China for care. It explains what usually happens, what to prepare, and where to find related specialists and hospitals.
No. It explains what usually happens so you can ask better questions; decisions are made with your own specialist.
The guides are published in English; interpretation and translation are arranged as a separate service.
Each guide links to related specialists and hospitals, or you can send an enquiry and a medical advisor will match you.
This 2025 consensus combines Western and traditional Chinese medicine to treat gallbladder inflammation and cut recurrence.
The 2025 Chinese consensus reaffirms ACE inhibitors as cornerstone therapy for hypertension, heart failure, and kidney disease, with clear…
The inherited small-vessel diseases that cause early stroke and dementia, how they are recognised on MRI and diagnosed genetically, and…
